Key result
Drug-eluting stent coatings play an important role in the performance of drug-eluting stents, particularly concerning the development of restenosis and thrombosis.
This review discusses the evolution of drug-eluting stent coatings and their impact on restenosis and thrombosis.
May guide DES selection amid thrombosis risk; leaves open optimal coating trials.
Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform, a drug carrier or so called ‘stent coating’ and a drug. As such, stent coating plays an important role in the performance of DES. This article will review the evolution of stent coatings and their role in the development of restenosis and thrombosis.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2012) conducted a review in Restenosis and thrombosis. Drug-eluting stent coatings was evaluated. Drug-eluting stent coatings play an important role in the performance of drug-eluting stents, particularly concerning the development of restenosis and thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: